HOSEIN CLYDE 4

What Happened

• Hosein Clyde, a director of DENTSPLY SIRONA Inc. (XRAY), was granted 22,822 shares on 2026-06-03 reported as an award/acquisition (code A) at $0.00 per share. The filing shows the grant amount (22,822 RSUs); no cash transaction or sale occurred.
• This is an equity award (not a purchase or sale) and therefore does not reflect an open-market buy or disposition.

Key Details

• Transaction date: 2026-06-03; Form 4 filed 2026-06-05 (appears to be timely).
• Reported price: $0.00 (award of RSUs); total cash value not reported on the Form 4.
• Shares owned after transaction: Not specified on this Form 4.
• Footnote: The grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from the date of grant.
• Transaction code: A (award/grant).

Context

• RSUs convert to actual shares only upon vesting (here, one year from grant); until then they are restricted and typically cannot be sold.
• Equity awards are a common form of compensation and do not necessarily indicate immediate insider buying or selling intent.